loader
Please Wait
Applying Filters...

Company Digital Content of Shouyuan Chemical

Menu

Digital content

Create Content with PharmaCompass, ask us

INTERVIEW #SpeakPharma

[Sponsored by another company]
“We’re unlocking life-changing potential in complex molecules, without sacrificing time to market”
This week, SpeakPharma interviews Mike Riley, CEO of Veranova, a leading contract development and manufacturing organization (CDMO) confidently mastering complex APIs as it marks its second year as an independent company. Riley discusses Veranova’s key achievements, including a US$ 30 million investment in their Devens, Massachusetts (US) site to expand capabilities in antibody-drug conjugates (ADCs) and highly potent APIs (HPAPIs), and how it is navigating the increasing complexity of molecules. 🔑 HIGHLIGHTS// Veranova’s key achievements / navigating the increasing complexity of molecules Veranova is celebrating its second year as a stand-alone company. Can you share Veranova’s key milestones and achievements in its first two years? We have achieved incredible milestones over the last two years, thanks to the dedication and hard work of our team. Our first 12 months focused on establishing ourselves as an independent CDMO by building on the 50 years of expertise that we brought with us. In addition, we expanded our capabilities and applied a more agile approach available to us as a company singularly focused on life sciences. This has allowed us to move into our second year with clear and strategic goals for generating growth in our sites, people, capabilities, and offerings. Since being appointed as CEO in May 2023, I’ve had the pleasure of witnessing some exciting growth milestones of my own. Most recently, we announced an estimated US$ 30 million investment in our Devens, Massachusetts, site. This expansion will allow us to build upon existing development and manufacturing capabilities in ADCs and HPAPIs that will address the growing demand for strong US-based capacity in these key drug modalities. We also appointed our Advisory Board, thereby bolstering Veranova’s in-house expertise. Made up of four distinguished leaders in pharma and biopharma – including Dr. Carolyn Bertozzi, the 2022 Nobel Laureate in Chemistry – the Board has provided thought-leadership, guidance and expertise as we develop and execute our strategic growth and ideas. We were also proud to be recognized as one of the Society of Chemical Manufacturers and Affiliates’ 12 companies for industry-leading safety programs in 2023 and as a part of the Medicine Maker’s Power List in 2024. 🔑 HIGHLIGHTS// US$ 30 million investment in our Devens, Massachusetts, site / appointed our Advisory Board Molecules are becoming increasingly complex. Can you elaborate on how Veranova’s current capabilities are strategically designed to address this trend in the coming years? The pharmaceutical pipeline is witnessing an increasing number of complex and highly potent molecules. This trend is driven by the demand for more targeted, patient-centric therapeutics and the focus on innovative modalities such as ADCs and other bioconjugates. At Veranova, our expertise, world-class facilities, and scientific excellence enable us to provide our customers with the clarity and solutions needed to manage this development and manufacturing complexity and ultimately deliver the required treatments to customers and patients. Our people are key to this approach. We have an expert team ready to collaborate with customers at any point, from early development through large-scale commercial production. Our services include world-leading crystallization development, process development, and specialized manufacturing expertise for complex synthetic molecules, including those requiring chromatography capabilities. In many cases, we can provide all these under one roof. Our service offering to our customers is also based on the foundational element of strong quality and compliance systems. We operate multiple facilities approved by the US FDA, UK’s MHRA and other regulatory authorities and are continually focused on ways to strengthen our global quality management system. Looking ahead, we are focused on continually investing in our facilities and team to meet growing complexity, as evidenced by our recent announcement of new investment in our Devens site. This investment signals our commitment to providing state-of-the-art capacity and capabilities to enable these next-generation therapies to reach patients. It is a key milestone as we advance Veranova’s broader growth strategy. 🔑 HIGHLIGHTS// provide our customers with clarity and solutions / world-leading crystallization development / expertise for complex synthetic molecules / strong quality and compliance systems How is Veranova approaching the challenge of designing and manufacturing effective linker molecules for ADCs? As a leader in complex linker-payload synthesis, Veranova is committed to unlocking the life-changing potential of ADCs without letting their complexities slow down the development of much-needed cancer therapies. ADCs are intricate, multi-component molecules that require extensive expertise and agile collaboration to overcome unique development challenges. With over a decade of experience in ADC linker-payload systems, we have developed the ability to anticipate challenges and avoid common pitfalls. The ADC linker-payload components are complex structures that are difficult to crystallize and require specialized high-potent handling. Veranova’s differentiated combination of world-leading crystallization development capabilities, complex synthesis experience, chromatography expertise and high-potent-handling experience put us in a unique position to solve these challenges for customers and speed their products to the clinic. We prioritize getting it right the first time, minimizing change orders and ensuring high-quality results. We have developed a robust phase-appropriate strategy that is backed by state-of-the-art analytical equipment and regulatory procedures to ensure our partners can rapidly progress their ADC projects from pre-clinical to commercialization. 🔑 HIGHLIGHTS// unlocking the life-changing potential of ADCs / ensuring our partners can rapidly progress their ADC projects Can you specify how Veranova is using artificial intelligence (AI) to optimize manufacturing processes that can reduce costs and environmental footprint as well as speed up development? In May 2024, Veranova announced a partnership with Phorum.AI to leverage AI to optimize pharmaceutical manufacturing processes. This collaboration aims to enable the rapid development of processes that can drive efficiency and reduce costs while maximizing environmental sustainability. Our goal is to combine Veranova’s extensive empirical manufacturing dataset of owned APIs and drug master files with Phorum.AI’s computational chemistry engine in order to create a more powerful process-development tool for the benefit of Veranova’s and Phorum’s customers. At Veranova, we are constantly looking to employ innovative technologies and approaches to improve efficiency, accelerate time to market and reduce environmental footprint. We have the means to work with a variety of partners who have unique project requirements, without sacrificing time to market.  🔑 HIGHLIGHTS// partnership with Phorum.AI / create a more powerful process-development tool / improve efficiency, accelerate time to market and reduce environmental footprint

Impressions: 1609

https://www.pharmacompass.com/speak-pharma/we-re-unlocking-life-changing-potential-in-complex-molecules-without-sacrificing-time-to-market

#SpeakPharma With Veranova
10 Sep 2024

VLOG #PharmaReel

[Sponsored by another company]

DATA COMPILATION #PharmaFlow

[Sponsored by another company]
Excipient Market Overview: Roquette, Seqens, Evonik make strategic moves; new guidelines deal with contamination
The pharmaceutical industry has long recognized the critical role excipients or inactive ingredients play in drug formulation and delivery. Excipients can comprise up to 90 percent of a medicine's total ingredients and serve crucial functions as binders, disintegrants, coatings, preservatives, colors, and flavorings. According to recent market research, the pharmaceutical excipients market was valued at US$ 9.27 billion in 2023. It is growing at a compound annual growth rate (CAGR) of 7.03 percent and is projected to reach US$ 18.48 billion by 2032. The main factors driving market growth is an increased demand for multifunctional excipients, coupled with the expanding use of generic medications. The development in the biologics sector and advancements in nanotechnology are also contributing significantly to market growth. Major excipient providers include BASF, Evonik, Merck KGaA owned MilliporeSigma, Gangwal Healthcare, Roquette Frères, DuPont, Croda International, Seqens, Boai NKY Pharmaceuticals, PMC Isochem, Minakem, Kewpie Corporation, Ashland Global, SPI Pharma, Pfanstiehl, Nanjing Well Pharmaceutical, ICE Pharma, Anhui Ribobay Pharmaceutical and Nippon Fine Chemical.  View Our Dashboard on Major Excipient Companies in 2024 (Free Excel Available) WHO, India’s CDSCO tighten regulations; new GMP guidelines implemented to curb contamination Last year, the World Health Organization (WHO) issued a health alert linking at least 300 child deaths in the Gambia, Uzbekistan, and Indonesia to the ingestion of contaminated cough syrups containing unacceptable levels of diethylene glycol (DEG) and ethylene glycol (EG). In response to the tragic events, the WHO released two draft appendices to its guideline on good manufacturing practices (GMPs) for excipients this year. Manufacturers are now required to use suitable risk assessment tools to identify and mitigate potential hazards.  Since India-made cough syrups had been linked to the deaths, India’s drug regulator — Central Drugs Standard Control Organization (CDSCO) — took steps to prevent contamination, and advised drugmakers to only use pharmaceutical-grade excipients from approved sources. Furthermore, the Indian Health Ministry proposed amendments to the Drugs and Cosmetics Rules, 1945 to include details of excipients on drug labels. While listing all excipients on every strip of medicine may be challenging, the ministry suggested mentioning those causing hypersensitivity on the label. Applicants now mandatorily need to submit evidence of stability and safety of excipients. These regulatory developments have significant implications for excipient manufacturers and pharmaceutical companies worldwide. Leading pharmaceutical excipient firms like Gangwal Healthcare, Sigachi Industries, and Nitika Pharmaceuticals are well-positioned to meet these heightened quality and safety standards, given their long-standing commitment to producing high-quality, compliant excipients.  View Our Dashboard on Major Excipient Companies in 2024 (Free Excel Available)   Roquette buys IFF’s pharma unit for US$ 2.85 bn; Evonik opens new spray-drying facility in Darmstadt In a significant industry move, France-based Roquette entered into an agreement to acquire IFF's pharma solutions business in a deal valued at US$ 2.85 billion. This acquisition is set to rebalance family-owned Roquette’s portfolio around health and nutrition. The deal is expected to accelerate Roquette’s growth and significantly strengthen its presence in the excipients market. Evonik has opened a new facility for drying aqueous dispersions of its Eudragit polymers at its site in Darmstadt, Germany. The facility will help Evonik meet increasing demand from drugmakers for its oral drug delivery solutions. The plant uses green energy solutions. The company has also partnered University of Mainz to commercialize a new class of polyethylene glycols (PEG) lipids for nucleic acid delivery. Evonik’s Health Care business has been growing its nucleic acid drug and vaccine delivery portfolio.  Germany’s Johannes Gutenberg University of Mainz was the first to develop randomized polyethylene glycols (rPEGs). This collaboration aims to expand Evonik’s toolbox of technologies for nucleic acid-based medicines, offering an improved immunogenicity profile for lipid nanoparticle carriers used in mRNA vaccines and therapeutics. Asahi Kasei made significant strides in addressing a pressing industry concern that emerged in 2018 when potentially carcinogenic nitrosamine impurities were detected in several pharmaceuticals. Guided by regional authorities, such as the European Medicines Agency and the US Food and Drug Administration, the pharmaceutical industry has been carrying out extensive assessments and research to identify the cause of these impurities. In response to this challenge, Asahi Kasei developed its Ceolus microcrystalline cellulose with extremely low nitrite levels. The Japanese company achieved nitrite concentrations of 0.1 micrograms per gram or less, which is equivalent to 0.1 parts per million (ppm). The company also started full commercial operation of its second manufacturing facility for Ceolus in Japan, enhancing supply capacity and stability. JRS Pharma and Gujarat Microwax opened a state-of-the-art cotton-based croscarmellose sodium plant in Mehsana, Gujarat (India). This facility aims to produce high-quality excipients that meet global standards, potentially reducing India's dependency on imports and boosting its presence in the global excipient market. The Indian excipient industry accounts for less than 1 percent of the global market share.  View Our Dashboard on Major Excipient Companies in 2024 (Free Excel Available)   Seqens to advance innovative polymer; biologics, personalized medicine create demand for specialized excipients Recent industry collaborations highlight the ongoing innovation in novel excipients. France’s Seqens, with over 20 years of polymer development experience, was chosen by Pleryon Therapeutics to advance its leading osteoarthritis candidate – an innovative GMP polymer. This collaboration leverages Seqens’ newly expanded and modernized cGMP plant in Aramon, France, demonstrating the industry’s commitment to investing in advanced manufacturing capabilities for novel excipients.  The rise of biologics and personalized medicine has created a demand for specialized excipients capable of stabilizing complex molecules and enabling targeted drug delivery. Roquette’s launch of Lycagel Flex, a hydroxypropyl pemix for nutraceutical and pharmaceutical softgel capsules, exemplifies this trend. Built on Roquette’s market-first Lycagel pea starch technology, this plant-based alternative to gelatin offers manufacturers the flexibility to customize formulations for a range of production and end-user needs. The innovative pea starch foundation also underscores the industry’s move towards sustainable bio-based excipients. The trend towards patient-centric drug development has also influenced excipient innovation. Excipients that can improve palatability, ease of swallowing, or enable novel dosage forms (such as orally disintegrating tablets) are in high demand. For example, IFF brought a super disintegrant Ac-Di-Sol, that supports faster disintegration and drug dissolution in oral disintegrating tablets, improving patient experience.  View Our Dashboard on Major Excipient Companies in 2024 (Free Excel Available)   Our view The heightened regulatory scrutiny on excipients due to product contamination incidents has created a high risk perception and uncertainty around the regulatory acceptance of novel excipients. That said, novel excipients are central to the development of new drug modalities and therapies. Going forward, sustainability will also become an increasingly important factor in excipient selection and development. As the industry innovates towards biologics, personalized therapies, and patient-centric formulations, the role of high-quality, multifunctional excipients will only grow more vital in ensuring drug stability, bioavailability, and patient compliance. Companies that can navigate the complex regulatory landscape, invest in R&D, and offer high-quality, multifunctional excipients will be well-positioned to succeed in this evolving market.   

Impressions: 620

https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-seqens-evonik-make-strategic-moves-new-guidelines-deal-with-contamination

#PharmaFlow by PHARMACOMPASS
12 Sep 2024

NEWS #PharmaBuzz

[Sponsored by another company]read-more
read-more

https://www.taiwannews.com.tw/en/news/3606759

Matthew Strong TAIWAN NEWS
29 Dec 2018
Contact Shouyuan Chemical and get a quotation

Shouyuan Chemical is a supplier offers 131 products (APIs, Excipients or Intermediates).

Find a price of Abiraterone Acetate bulk offered by Shouyuan Chemical

Find a price of Aciclovir bulk offered by Shouyuan Chemical

Find a price of Acyclovir Sodium bulk offered by Shouyuan Chemical

Find a price of Adefovir bulk offered by Shouyuan Chemical

Find a price of Adefovir Dipivoxil bulk offered by Shouyuan Chemical

Find a price of Adenosine bulk offered by Shouyuan Chemical

Find a price of Afatinib bulk offered by Shouyuan Chemical

Find a price of Agomelatine bulk offered by Shouyuan Chemical

Find a price of Amifostine bulk offered by Shouyuan Chemical

Find a price of Amitriptyline Hydrochloride bulk offered by Shouyuan Chemical

Find a price of Anastrozole bulk offered by Shouyuan Chemical

Find a price of Aprepitant bulk offered by Shouyuan Chemical

Find a price of Arformoterol Tartrate bulk offered by Shouyuan Chemical

Find a price of Asenapine Maleate bulk offered by Shouyuan Chemical

Find a price of Azasetron Hydrochloride bulk offered by Shouyuan Chemical

Find a price of Betahistine Dimesilate bulk offered by Shouyuan Chemical

Find a price of Calcium Folinate bulk offered by Shouyuan Chemical

Find a price of Cangrelor bulk offered by Shouyuan Chemical

Find a price of Capecitabine bulk offered by Shouyuan Chemical

Find a price of Capreomycin bulk offered by Shouyuan Chemical

Find a price of Caspofungin bulk offered by Shouyuan Chemical

Find a price of Ciclopirox bulk offered by Shouyuan Chemical

Find a price of Ciclopirox Olamine bulk offered by Shouyuan Chemical

Find a price of Cinacalcet Hydrochloride bulk offered by Shouyuan Chemical

Find a price of Clemastine bulk offered by Shouyuan Chemical

Find a price of Clopidogrel bulk offered by Shouyuan Chemical

Find a price of Conivaptan bulk offered by Shouyuan Chemical

Find a price of Crotamiton bulk offered by Shouyuan Chemical

Find a price of Cyclophosphamide bulk offered by Shouyuan Chemical

Find a price of Cytarabine bulk offered by Shouyuan Chemical

Find a price of Darifenacin Hydrobromide bulk offered by Shouyuan Chemical

Find a price of Dasatinib bulk offered by Shouyuan Chemical

Find a price of Dolasetron Mesylate bulk offered by Shouyuan Chemical

Find a price of Doripenem bulk offered by Shouyuan Chemical

Find a price of Entecavir bulk offered by Shouyuan Chemical

Find a price of Enzalutamide bulk offered by Shouyuan Chemical

Find a price of Erlotinib Hydrochloride bulk offered by Shouyuan Chemical

Find a price of Esomeprazole Sodium bulk offered by Shouyuan Chemical

Find a price of Eszopiclone bulk offered by Shouyuan Chemical

Find a price of Etoposide bulk offered by Shouyuan Chemical

Find a price of Everolimus bulk offered by Shouyuan Chemical

Find a price of Famciclovir bulk offered by Shouyuan Chemical

Find a price of Fasudil bulk offered by Shouyuan Chemical

Find a price of Favipiravir bulk offered by Shouyuan Chemical

Find a price of Fenticonazole Nitrate bulk offered by Shouyuan Chemical

Find a price of Fludarabine Phosphate bulk offered by Shouyuan Chemical

Find a price of Flunarizine bulk offered by Shouyuan Chemical

Find a price of Fluoxymesterone bulk offered by Shouyuan Chemical

Find a price of Fluticasone Propionate bulk offered by Shouyuan Chemical

Find a price of Fulvestrant bulk offered by Shouyuan Chemical

Find a price of Ganciclovir bulk offered by Shouyuan Chemical

Find a price of Ganciclovir Sodium bulk offered by Shouyuan Chemical

Find a price of Gefitinib bulk offered by Shouyuan Chemical

Find a price of Gemifloxacin bulk offered by Shouyuan Chemical

Find a price of Glycopyrronium Bromide bulk offered by Shouyuan Chemical

Find a price of Ifosfamide bulk offered by Shouyuan Chemical

Find a price of Iloperidone bulk offered by Shouyuan Chemical

Find a price of Imatinib Mesylate bulk offered by Shouyuan Chemical

Find a price of Isavuconazonium Sulfate bulk offered by Shouyuan Chemical

Find a price of Ketoconazole bulk offered by Shouyuan Chemical

Find a price of L-Ornithine L-aspartate bulk offered by Shouyuan Chemical

Find a price of Lacosamide bulk offered by Shouyuan Chemical

Find a price of Lercanidipine bulk offered by Shouyuan Chemical

Find a price of Lesinurad bulk offered by Shouyuan Chemical

Find a price of Letrozole bulk offered by Shouyuan Chemical

Find a price of Levalbuterol Hydrochloride bulk offered by Shouyuan Chemical

Find a price of Levalbuterol Tartrate bulk offered by Shouyuan Chemical

Find a price of Levetiracetam bulk offered by Shouyuan Chemical

Find a price of Levosimendan bulk offered by Shouyuan Chemical

Find a price of Linagliptin bulk offered by Shouyuan Chemical

Find a price of Linezolid bulk offered by Shouyuan Chemical

Find a price of Mafenide bulk offered by Shouyuan Chemical

Find a price of Methasterone bulk offered by Shouyuan Chemical

Find a price of Methenolone Acetate bulk offered by Shouyuan Chemical

Find a price of Methenolone Enanthate bulk offered by Shouyuan Chemical

Find a price of Milrinone bulk offered by Shouyuan Chemical

Find a price of Miriplatin Monohydrate bulk offered by Shouyuan Chemical

Find a price of Moxifloxacin Hydrochloride bulk offered by Shouyuan Chemical

Find a price of Nelarabine bulk offered by Shouyuan Chemical

Find a price of Ondansetron Hydrochloride bulk offered by Shouyuan Chemical

Find a price of Oseltamivir Phosphate bulk offered by Shouyuan Chemical

Find a price of Oxaceprol bulk offered by Shouyuan Chemical

Find a price of Oxandrolone bulk offered by Shouyuan Chemical

Find a price of Oxybutynin bulk offered by Shouyuan Chemical

Find a price of Palonosetron bulk offered by Shouyuan Chemical

Find a price of Parecoxib Sodium bulk offered by Shouyuan Chemical

Find a price of Pelitinib bulk offered by Shouyuan Chemical

Find a price of Penciclovir bulk offered by Shouyuan Chemical

Find a price of Phentolamine Mesylate bulk offered by Shouyuan Chemical

Find a price of Pirenoxine Sodium bulk offered by Shouyuan Chemical

Find a price of Pirenzepine Hydrochloride bulk offered by Shouyuan Chemical

Find a price of Posaconazole bulk offered by Shouyuan Chemical

Find a price of Pradax bulk offered by Shouyuan Chemical

Find a price of Pramipexole Dihydrochloride bulk offered by Shouyuan Chemical

Find a price of Pregabalin bulk offered by Shouyuan Chemical

Find a price of Prucalopride Succinate bulk offered by Shouyuan Chemical

Find a price of Reboxetine Mesylate bulk offered by Shouyuan Chemical

Find a price of Regorafenib bulk offered by Shouyuan Chemical

Find a price of Repaglinide bulk offered by Shouyuan Chemical

Find a price of Rivaroxaban bulk offered by Shouyuan Chemical

Find a price of Rocuronium Bromide bulk offered by Shouyuan Chemical

Find a price of Ropivacaine Hydrochloride bulk offered by Shouyuan Chemical

Find a price of Salbutamol Sulphate bulk offered by Shouyuan Chemical

Find a price of Salmeterol Xinafoate bulk offered by Shouyuan Chemical

Find a price of Silodosin bulk offered by Shouyuan Chemical

Find a price of Silver Sulfadiazine bulk offered by Shouyuan Chemical

Find a price of Sitagliptin Phosphate bulk offered by Shouyuan Chemical

Find a price of Solifenacin Succinate bulk offered by Shouyuan Chemical

Find a price of Solithromycin bulk offered by Shouyuan Chemical

Find a price of Sorafenib bulk offered by Shouyuan Chemical

Find a price of Tamoxifen Citrate bulk offered by Shouyuan Chemical

Find a price of Tamsulosin bulk offered by Shouyuan Chemical

Find a price of Tebipenem Pivoxil Hydrobromide bulk offered by Shouyuan Chemical

Find a price of Temsirolimus bulk offered by Shouyuan Chemical

Find a price of Tenofovir bulk offered by Shouyuan Chemical

Find a price of Tenofovir Disoproxil Fumarate bulk offered by Shouyuan Chemical

Find a price of Terbinafine Hydrochloride bulk offered by Shouyuan Chemical

Find a price of Ticagrelor bulk offered by Shouyuan Chemical

Find a price of Tirofiban bulk offered by Shouyuan Chemical

Find a price of Tofacitinib Citrate bulk offered by Shouyuan Chemical

Find a price of Trenbolone Acetate bulk offered by Shouyuan Chemical

Find a price of Trenbolone Cyclohexylmethylcarbonate bulk offered by Shouyuan Chemical

Find a price of Trenbolone Enanthate bulk offered by Shouyuan Chemical

Find a price of Ursodeoxycholic Acid bulk offered by Shouyuan Chemical

Find a price of Valacyclovir Hydrochloride bulk offered by Shouyuan Chemical

Find a price of Valdecoxib bulk offered by Shouyuan Chemical

Find a price of Valganciclovir Hydrochloride bulk offered by Shouyuan Chemical

Find a price of Vidarabine bulk offered by Shouyuan Chemical

Find a price of Vorapaxar Sulfate bulk offered by Shouyuan Chemical

Find a price of Zofenopril Calcium bulk offered by Shouyuan Chemical

Find a price of Glycopyrrolate cation bulk offered by Shouyuan Chemical